although
viral
infect
caus
minor
symptom
certain
number
result
seriou
ill
viral
diseas
symptom
result
direct
viral
replic
within
host
cell
indirect
immunopatholog
consequ
dendrit
cell
dc
key
determin
viral
diseas
outcom
activ
immun
respons
viral
infect
direct
cell
toward
distinct
helper
type
respons
certain
virus
abl
skew
cytokin
secret
dc
induc
andor
downregul
immun
system
aim
facilit
prolong
releas
progeni
thu
interact
dc
virus
often
result
absenc
diseas
complet
recoveri
natur
function
dc
prevail
may
lead
chronic
ill
death
function
outmanoeuvr
virus
exploit
dc
virus
major
target
immun
system
varieti
viral
pathogenassoci
molecular
pattern
pamp
high
repetit
capsom
andor
peplom
virion
surfac
product
uniqu
rna
replic
intermedi
genom
modif
other
recogn
marker
viral
invas
respons
molecul
immun
effector
cell
see
figur
integr
stimuli
deliv
differ
viral
pamp
lead
inflamm
immun
activ
turn
key
compon
pathogenesi
recoveri
viral
infect
dendrit
cell
dc
possess
properti
abil
enabl
act
uniqu
immun
live
adjuv
like
antigenpres
cell
perform
multipl
immunogen
task
includ
prime
cell
express
special
costimulatori
surfac
molecul
ii
crosspresent
present
exogen
antigen
context
mhc
class
molecul
lymphocyt
addit
present
mhc
class
iirestrict
peptid
iii
polar
cell
variou
th
phenotyp
dc
activ
normal
trigger
pathogen
via
varieti
receptor
molecul
includ
releas
distinct
interleukin
il
direct
regul
cell
differenti
inde
secret
solubl
mediat
seem
respons
th
phenotyp
differenti
consid
signal
mhcpeptid
recognit
signal
contact
costimulatori
molecul
signal
secret
tumor
necrosi
factor
tnf
interferon
ifn
associ
skew
cell
toward
phenotyp
cell
produc
absenc
cytokin
presenc
addit
transform
growth
factor
tgf
b
induc
promot
gener
regulatori
treg
cell
inhibit
gener
treg
cell
induc
product
helper
cell
suggest
anoth
reciproc
development
pathway
cell
turn
treg
cell
hinder
dc
andor
normal
cell
activ
cell
involv
inflammatori
autoimmun
reaction
due
differ
origin
distribut
tissu
express
surfac
receptor
dc
divid
convent
cdc
plasmacytoid
dc
pdc
differ
immunomodulatori
function
preferenti
react
distinct
microbi
stimuli
cdc
also
known
myeloid
dc
includ
migratori
cell
lymphoidresid
cell
cooper
essenti
one
anoth
turn
cell
respons
cdc
mostli
devot
take
antigen
steadi
state
present
cell
activ
matur
state
recent
evid
show
earli
antigen
present
lymphoidresid
dc
initi
activ
trap
antigenspecif
lymphocyt
drain
lymph
node
migratori
dc
interact
cell
induc
clonal
expans
addit
cdc
recogn
cytoplasm
viral
rna
endosom
tolllik
receptor
tlr
bind
doublestrand
rna
cytoplasm
receptor
retinoicacidinduc
protein
rigi
helicas
shown
bind
triphosphoryl
end
singlestrand
rna
present
certain
viral
genom
melanomadifferentiationassoci
gene
start
type
ifn
product
studi
human
dc
cdc
gener
vitro
differenti
peripher
blood
monocyt
presenc
specif
cytokin
extens
use
mani
studi
howev
result
obtain
vitrogener
cdc
must
interpret
caution
sinc
recent
evid
indic
vitro
condit
may
select
least
one
specif
subset
respect
probabl
abund
new
insight
field
brought
studi
human
mice
exhibit
longterm
system
human
cell
reconstitut
vivo
allow
manifest
differenti
respons
human
dc
differ
pathogen
dc
second
subset
pdc
seem
design
part
first
line
defens
viral
intracellular
parasit
replic
express
endosom
nucleicacid
sens
trigger
mostli
respons
releas
type
ifn
cell
recent
howev
pdc
shown
also
capabl
crosspres
viral
antigen
behav
readymad
store
mhc
class
charg
endosom
independ
proteasom
activ
pdc
therefor
also
abl
quickli
prime
cytotox
activ
upon
interact
viru
pdc
normal
found
blood
lymphoid
organ
purifi
small
number
human
peripher
blood
recogn
cell
discuss
data
role
vivo
indic
reduct
pdc
respons
invers
correl
sever
viral
diseas
present
antigen
cell
dc
must
move
locat
lymph
node
abil
migrat
lymph
node
well
express
costimulatori
molecul
respons
activ
cell
germin
center
acquir
matur
state
also
call
activ
achiev
viru
uptak
trigger
one
two
kind
receptor
receptor
recogn
pamp
includ
tlr
cell
surfac
endosom
well
cytosol
react
intracellular
parasit
motif
ii
receptor
recogn
cytokin
chemokin
cell
surfac
protein
produc
host
eg
tnf
superfamili
matur
also
lead
express
differ
surfac
molecul
one
best
marker
human
dc
matur
highli
express
matur
dc
membranebound
solubl
secret
form
least
circumst
solubl
seem
immunosuppress
effect
demonstr
abil
prevent
autoimmun
encephalomyel
mice
suscept
permiss
target
cell
present
site
viral
entri
host
cdc
amongst
first
cell
encount
virus
simpli
due
avail
everi
possibl
entri
site
bodi
formal
shown
ex
vivo
organ
cultur
system
reproduc
human
vagina
set
cell
present
vagin
epithelium
langerhan
dc
first
cell
invad
viru
virus
bind
dc
activ
produc
proinflammatori
cytokin
antivir
molecul
andor
get
degrad
present
specif
cell
peptid
thank
viral
infect
go
clinic
unnot
heal
spontan
dealt
effici
host
immun
system
certain
virus
howev
success
replic
dc
case
cell
act
like
permiss
cell
ad
consequ
migrat
across
bodi
result
facilit
spread
infect
addit
altern
activ
defens
third
possibl
outcom
virusdc
interact
dc
digest
present
viral
particl
pick
preserv
inactiv
virion
transport
lymph
node
promot
target
cell
infect
overal
result
least
certain
viral
infect
thu
envis
balanc
prevail
activ
dc
trigger
immun
respons
versu
abil
virus
exploit
dc
hamper
uniqu
immun
function
review
mainli
focu
insight
brought
effect
virus
exert
upon
natur
function
dc
last
year
refer
excel
recent
review
subject
virus
exhibit
number
specif
featur
make
highli
immunogen
figur
dc
evolv
specif
surfac
molecul
uptak
pathogen
addit
express
number
specif
receptor
certain
virus
dcsign
dendrit
cell
specif
nonintegrin
close
rel
dcsignr
lsign
found
liver
endothelium
intens
studi
pathogen
receptor
type
ii
transmembran
ctype
lectin
specif
mannos
fucos
residu
promot
adhes
dc
endothelia
therefor
involv
dc
traffick
although
first
consid
express
cdc
dcsign
later
recogn
express
also
b
lymphocyt
macrophag
although
detect
surfac
langerhan
cell
dcsign
receptor
essenti
establish
initi
dct
cell
contact
cell
activ
soon
understood
dcsign
also
target
pathogen
rang
mycobacteria
major
human
virus
dcsign
owe
properti
bind
nlink
glycan
substitu
viral
spike
therebi
enabl
viru
entri
cell
line
express
low
level
specif
receptor
may
function
receptor
altern
specif
one
nonessenti
adhes
factor
concentr
virion
onto
cell
bind
dcsign
sever
pathogen
also
report
regul
inflamm
cytokin
secret
dc
via
nfkb
addit
recent
shown
dcsign
divert
proteasom
associ
leukocytespecif
protein
cell
infect
vitro
suggest
role
molecul
crosspresent
cell
also
role
format
infecti
synaps
see
virus
found
bind
dc
via
dcsign
includ
herpesvirus
ebola
viru
sar
coronaviru
human
hepat
c
viru
hcv
dengu
viru
dv
still
unclear
whether
dcsign
relat
lectin
actual
pathogenrecognit
receptor
rather
antigenbind
receptor
whose
function
subvert
pathogen
langerin
membran
marker
express
sole
langerhan
cell
express
dcsign
stark
contrast
dcsign
langerin
shown
intern
virion
birbeck
granul
degrad
anoth
molecul
membran
molecul
bind
certain
virus
discov
first
mous
human
pandcspecif
surfac
marker
express
high
level
dc
cell
area
lymph
node
steadi
state
even
matur
contrast
mani
endocytosi
receptor
recycl
cell
surfac
earli
endosom
mannos
receptor
target
antigen
murin
spleen
cell
allow
reach
endolysosom
rich
mhc
class
ii
product
enhanc
effici
antigen
present
cell
human
also
prove
use
target
prime
mhc
class
class
ii
envis
promis
candid
molecul
target
antigen
dc
vivo
purpos
prime
cell
howev
surfac
molecul
like
heparan
sulfat
fcc
mannos
receptor
also
contribut
uptak
virus
dc
novel
virusbind
molecul
discov
continu
surfac
dc
last
one
ctype
lectin
surfac
receptor
dcir
fate
virion
encount
dc
partli
determin
receptor
bind
shown
hiv
bind
specif
receptor
may
determin
entri
replic
wherea
bind
dcsign
may
lead
mostli
transmiss
viru
cell
andor
degrad
via
proteasom
result
mhc
class
present
bind
langerin
may
lead
lysosom
degrad
mhc
class
ii
load
final
particular
circumst
may
affect
viral
bind
effici
infect
exampl
semenderiv
enhanc
viru
infect
sevi
fiber
abund
human
semen
captur
hiv
virion
promot
attach
target
cell
molecul
may
allow
virion
bypass
uptak
dcsign
viral
infect
signific
damag
host
side
product
activ
immun
system
skew
helper
cell
respons
toward
treg
dc
pivot
polar
th
respons
definit
key
determin
pathogenet
outcom
viral
infect
also
contribut
determin
infecti
diseas
sever
certain
virus
promot
persist
favor
product
cytokin
alter
cytokin
secret
although
benefici
recoveri
helminth
infest
respons
known
detriment
effect
promot
inflamm
allergi
fibrosi
viral
infect
trigger
dcsign
propos
central
role
polar
th
respons
toward
viral
persist
new
evid
show
dcsign
bind
hiv
human
cdc
caus
activ
rho
guanin
nucleotideexchang
factor
larg
turn
essenti
format
infecti
synaps
downregul
secret
thu
activ
dcsign
may
favor
product
cytokin
profil
infect
anoth
viral
strategi
achiev
environ
induc
dc
cell
type
secret
cytokin
best
known
exampl
probabl
respiratori
syncyti
viru
rsv
although
induc
dc
matur
virul
rsv
strain
shown
inhibit
ifna
secret
human
dc
mice
rsv
infect
establish
environ
lead
airway
infiltr
least
patient
present
sign
lung
injuri
addit
vaccin
attempt
inactiv
rsv
led
exacerb
diseas
interest
recent
vaccin
mice
rsv
success
obtain
bcg
potent
induc
recombin
n
protein
rsv
protect
found
mediat
mostli
cellular
immun
respons
environ
seem
import
virus
go
far
directli
encod
protein
interfer
immunoregulatori
cytokin
protein
immunomodulatori
andor
cytokinelik
activ
ie
human
cytomegaloviru
distinct
stage
dc
gener
may
alter
viral
infect
hematopoiet
progenitor
differenti
matur
even
figur
mice
dc
progenitor
gener
influenc
abl
give
rise
dc
subset
induc
antigenspecif
expans
function
treg
cell
strong
suppress
function
role
treg
cell
normal
downregul
immun
inflammatori
respons
part
heal
process
may
activ
creat
immunosuppress
environ
certain
viral
infect
matur
essenti
dc
function
virus
interfer
experi
perform
human
monocytederiv
cdc
show
differ
virus
downregul
distinct
stage
event
matur
process
hcv
protein
shown
downregul
express
hladr
measl
viru
rsv
render
immun
synaps
cdc
cell
unstabl
downregul
express
sever
costimulatori
molecul
cdc
influenza
viru
protein
block
matur
hand
virus
vaccinia
viru
may
induc
cdc
matur
interfer
antigen
present
nevertheless
outcom
viral
diseas
thought
partli
link
number
balanc
pdc
cdc
basi
observ
made
patient
patient
infect
hsv
sever
diseas
found
invers
correl
number
circul
pdc
blunt
ifna
releas
respons
earli
phase
infect
clinic
data
show
patient
hsvassoci
acut
retin
necrosi
lower
number
peripher
blood
pdc
exhibit
impair
immun
respons
similar
find
obtain
patient
infect
dv
along
line
primari
infect
pdc
found
reduc
number
peripher
blood
reduct
associ
higher
plasma
viral
load
import
pdc
also
demonstr
mous
model
preferenti
deplet
pdc
cdc
rsv
infect
increas
pdc
number
correl
protect
reduc
number
pdc
may
either
genet
determin
given
host
viral
diseas
expect
consequ
sever
due
poor
ifn
type
respons
instanc
pdc
number
may
viral
determin
suggest
find
show
patient
chronic
hepat
c
exhibit
reduc
number
pdc
possibl
result
apoptosi
induc
interact
hcv
core
protein
altern
decreas
number
pdc
may
occur
consequ
retent
lymphoid
organ
possibl
due
higher
viral
replic
site
suggest
hiv
interestingli
recent
studi
suggest
aid
pathogenesi
human
might
stem
failur
adapt
immun
respons
control
viral
replic
consequ
continu
stimul
pdc
nk
cell
substanti
amount
circul
viru
suggest
author
mechan
might
gener
virus
reach
high
titer
blood
target
pdc
involv
viral
pathogen
particularli
evid
lung
organ
inflammatori
reaction
well
recogn
part
pathogen
scenario
mani
viral
diseas
long
notic
asthmat
reaction
may
link
pulmonari
infect
virus
especi
paramyxovirus
rhinovirus
influenza
increas
evid
seem
highlight
role
dcmediat
polar
immun
respons
develop
hyperreact
cytokin
profil
creat
il
predomin
chronic
diseas
usual
evid
whilst
recoveri
pulmonari
infect
gener
associ
profil
pdc
detect
pulmonari
site
viral
infect
recent
studi
describ
describ
link
cell
allerg
reactiv
murin
model
dc
found
upregul
highaffin
ige
receptor
infect
lung
sendai
viru
result
ifn
type
secret
pdc
express
receptor
essenti
develop
mucou
cell
metaplasia
one
sign
airway
hyperreact
quit
number
virus
find
suitabl
intracellular
condit
multipli
dc
abil
replic
cell
certainli
repres
advantag
sinc
dc
locat
site
first
encount
host
may
repres
first
site
primari
replic
replic
virus
may
influenc
dc
physiolog
dv
exampl
give
rise
complex
diseas
strictli
depend
immunopatholog
typic
featur
dengu
greater
diseas
sever
notic
individu
undergon
prior
infect
differ
dv
serotyp
antibodydepend
enhanc
believ
respons
phenomenon
recent
evid
also
link
increas
product
dv
proinflammatori
cytokin
dvinfect
matur
dc
expos
dvimmun
sera
phenomenon
shown
mediat
fccriia
downregul
dcsign
express
human
cdc
gener
vitro
suggest
entri
dv
immun
complex
via
fccriia
dcsign
might
activ
cytokin
product
dv
transmit
direct
inocul
infect
saliva
mosquito
host
skin
therefor
skin
dc
probabl
amongst
first
permiss
cell
encount
express
high
level
dcsign
light
evid
show
dc
precursor
captur
dv
mostli
dcsign
permiss
viru
replic
dv
infect
replic
probabl
initi
via
dcsign
compound
antibodi
produc
herpesvirus
also
capabl
replic
dc
encod
number
earli
gene
product
immedi
affect
dc
physiolog
favor
immun
evas
sever
member
herpesviru
famili
attack
express
costimulatori
molecul
surfac
dc
vitro
exampl
induc
specif
degrad
earli
hour
infect
human
cdc
gener
vitro
known
replic
dc
result
mostli
downregul
activ
antigenpres
cell
immun
dysfunct
induc
hsv
includ
dowregul
express
sever
costimulatori
molecul
matur
dc
mostli
mediat
viral
protein
directli
togeth
inhibit
secret
solubl
mediat
class
iirestrict
present
also
hamper
similarli
mous
cytomegaloviru
alter
balanc
stimulatori
molecul
inhibitori
one
surfac
infect
murin
dc
immunosuppress
mechan
may
prevail
certain
stage
host
life
lead
reactiv
herp
infect
howev
one
must
bear
mind
percentag
dc
infect
larg
fraction
dc
vivo
expect
perform
effici
crosspresent
prime
shown
ex
vivo
dc
patient
infect
cytomegaloviru
hiv
also
report
preferenti
infect
small
fraction
blood
cdc
infect
dc
either
prevent
matur
may
select
subset
dc
resist
matur
case
hivinfect
dc
exhibit
weak
immunostimulatori
activ
lentivirus
mayb
virus
well
develop
exquisit
way
exploit
dc
traffick
function
get
concentr
andor
onto
dc
mucos
site
typic
make
contact
host
shuttl
lymph
node
get
effici
transfer
cell
phenotyp
infect
knowledg
lentivir
transfer
dc
cell
origin
studi
vitrogener
human
cdc
hiv
sequestr
dcsign
help
hiv
evad
immun
respons
spread
suscept
cell
structur
call
infecti
synaps
form
dct
cell
contact
surfac
figur
engag
dcsign
surfac
human
cdc
hiv
stimul
rhogtpas
activ
found
essenti
format
actin
structur
give
origin
infecti
synaps
hiv
replic
actual
transfer
hiv
cdc
cell
report
depend
receptor
cluster
actin
tubul
format
long
evid
figur
matur
cdc
seem
enhanc
virion
transfer
activ
direct
target
cell
dcmediat
viral
transmiss
appear
conserv
across
lentivirus
infect
differ
speci
simian
immunodefici
viru
siv
shown
effici
transfer
activ
cell
monocytederiv
immatur
dc
vitro
felin
immunodefici
viru
fiv
suggest
import
mechan
lentivir
pathogenesi
howev
virus
shown
undergo
dcmediat
transmiss
lymphocyt
amongst
recent
studi
one
infect
dc
turn
rapidli
transfer
viru
autolog
primari
cell
dcmediat
transfer
involv
heparan
sulfat
proteoglycan
result
product
infect
transform
transfect
cell
even
nonlymphotrop
virus
hcv
may
exploit
mechan
hcvpseudotyp
virion
shown
transinfect
cell
hepatoma
line
captur
dc
cell
express
lsign
recent
studi
show
dcsign
involv
direct
dc
infect
subsequ
transmiss
measl
viru
indic
promin
role
dc
initi
dissemin
yet
anoth
viru
infect
exploit
dc
improv
immun
respons
vaccin
unravel
detail
dc
biolog
brought
hope
possibl
use
immunoadjuv
modul
enhanc
immun
respons
viral
infect
clinic
trial
evalu
vaccin
patient
experiment
anim
ex
vivogener
cdc
puls
tumor
antigen
provid
proofofprincipl
therapeut
effect
may
obtain
way
howev
gave
rise
surprisingli
studi
address
concurr
issu
whether
dc
use
boost
protect
immun
virus
skew
immun
respons
toward
direct
heal
gener
matur
process
dc
follow
determin
potenti
polar
cell
respons
direct
differ
strategi
method
produc
clinic
use
dc
experi
use
dc
therapi
hiv
siv
infect
explor
result
publish
obtain
untreat
hivinfect
patient
vaccin
autolog
monocytederiv
dc
load
autolog
inactiv
hiv
year
follow
vaccin
patient
exhibit
plasma
viral
load
decreas
significantli
correl
percentag
hivspecif
cell
knowledg
trial
report
success
use
dc
therapi
human
viral
diseas
recent
clinic
trial
patient
hiv
carri
inject
monocytederiv
dc
load
peptid
gag
pol
env
protein
signific
increas
cell
immun
report
viremia
measur
similarli
human
papillomaviru
hpv
fulllength
antigenpuls
matur
autolog
cdc
vaccin
shown
gener
boost
immun
respons
patient
cervic
cancer
overal
benefici
clinic
effect
yet
report
protocol
gener
dc
studi
includ
growth
adher
autolog
peripher
blood
monocyt
vitro
presenc
granulocyt
macrophag
coloni
stimul
factor
gmcsf
matur
induct
antigen
load
cocktail
tnfa
cytokin
recommend
clinicalgrad
dc
product
cat
infect
fiv
accept
good
nonprim
model
studi
aid
investig
vaccin
cat
autolog
cdc
gener
vitro
load
whole
inactiv
fiv
case
matur
could
achiev
use
lp
sinc
felin
cytokin
unavail
time
studi
agent
abl
induc
abil
prime
alloreact
cat
allogen
cell
result
encourag
cat
exhibit
antibodi
cellular
immun
fiv
antigen
protect
challeng
infecti
fiv
achiev
hypothesi
elicit
memori
respons
infect
cat
might
less
demand
induc
primari
respons
success
test
vaccin
protocol
fivinfect
cat
case
also
assess
viremia
level
vaccin
sustain
reduct
viral
load
main
goal
latter
approach
detect
increas
cellular
respons
fiv
effect
viral
load
seen
one
hypothesi
explain
failur
dc
vaccin
protocol
alter
cours
fiv
infect
might
dc
suitabl
type
term
molecul
express
case
might
interest
test
differ
protocol
dc
gener
matur
explor
effect
differ
cytokin
matur
stimuli
gener
protect
dc
hypothesi
also
suggest
recent
data
obtain
mous
model
suggest
dc
gener
vitro
gmcsf
might
appropri
one
achiev
protect
immun
activ
protocol
gener
dc
vitro
often
consid
cumbersom
achiev
suffici
high
cell
number
appropri
matur
statu
sever
group
therefor
aim
target
antigen
dc
vivo
encourag
result
mani
report
show
target
dc
via
differ
receptor
langerin
fccr
other
improv
abil
differ
antigen
induc
cell
continu
studi
need
assess
whether
skew
immun
respons
carri
target
antigen
surfac
dc
molecul
time
remain
seen
whether
vitroderiv
dc
effici
induc
immun
also
direct
immun
respons
specif
type
iceberg
effect
wherebi
viral
infect
recov
symptom
minor
infect
lead
seriou
ill
death
suggest
frequent
outcom
infect
immun
activ
indirectli
prove
prevail
role
dc
howev
virus
may
also
exploit
dc
sever
step
life
cycl
limit
immun
respons
rather
actual
suppress
addit
wellknown
advantag
virus
preserv
host
rather
impoverish
possibl
replic
reservoir
thu
success
viru
may
view
one
permit
immun
reaction
take
place
new
gener
virion
releas
host
environ
key
event
respect
relationship
establish
virus
dc
virus
replic
dc
mere
alterhijack
function
benefit
shed
light
relationship
might
provid
mean
develop
altern
classic
vaccin
strategi
design
immunotherapeut
approach
chronic
viral
infect
global
impact
hcv
hiv
insight
field
gain
vivo
studi
aim
confirm
great
deal
result
obtain
vitro
last
decad
